arrow
C

Christoph E. Heilig

german cancer research center
H指数:23
被引数:2,765

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Clinically actionable genomic and transcriptomic landscape of advanced neuroendocrine neoplasms

晚期神经内分泌肿瘤的临床可操作基因组学和转录组学景观

Med
IF11.8
2026-04-300
OAAI
Multi-layered molecular profiling informs the diagnosis and targeted therapy of desmoplastic small round cell tumor

多层分子分析为硬化性小圆细胞肿瘤的诊断和靶向治疗提供信息

2026-04-090
OA
The Knowledge Connector decision support system for multiomics-based precision oncology

基于多组学的精准肿瘤学知识连接器决策支持系统

2026-01-190
OAAI
Rationale and design of the PAMSARC (pasireotide as maintenance treatment with monthly deep intramuscular injection in SSTR2/3/ 5-expressing synovial sarcoma and desmoplastic small round cell tumor) multicenter phase 2 trial

PAMSARC(在表达SSTR2/3/5的滑膜肉瘤和弥漫性小圆细胞瘤中使用帕西瑞肽作为每月深部肌肉注射的维持治疗)多中心II期试验的原理与设计

2025-09-010
OAAI
CDK4/6 inhibition in advanced chordoma: final results of the NCT PMO-1601 trial

CDK4/6抑制剂在晚期软骨肉瘤中的应用:NCT PMO-1601试验的最终结果

2025-07-070
OA
Comprehensive genomic and transcriptomic analysis enables molecularly guided therapy options in peritoneal and pleural mesothelioma

全面的基因组学和转录组学分析能够实现针对腹膜和胸膜间皮瘤的分子引导治疗方案。

2025-04-010
OAAI
Multi-omic profiling in cholangiocarcinoma to enable scientific advancement within the DKFZ/NCT/DKTK MASTER study

多组学分析在胆管癌中的应用,以推动DKFZ/NCT/DKTK MASTER研究中的科学进展

2024-09-010
PRE
Inavolisib in cancers with activating PIK3CA mutations: Results from the CRAFT trial

Inavolisib在具有激活性PIK3CA突变的癌症中的研究:CRAFT试验的结果

2024-09-010
PRE
Randomized phase II study of trabectedin/olaparib compared to physician's choice in subjects with previously treated advanced or recurrent solid tumors harboring DNA repair deficiencies

随机对照II期研究,比较曲贝替定/奥拉帕利与医生选择方案在既往接受过治疗的、存在DNA修复缺陷的晚期或复发性实体瘤患者中的疗效。

2024-09-010
PRE
Pasireotide as maintenance treatment in SSTR2/3/5-expressing synovial sarcoma and desmoplastic small round cell tumor: The PAMSARC study

帕希瑞otide作为SSTR2/3/5表达型滑膜肉瘤和硬化性小圆细胞瘤的维持治疗:PAMSARC研究

2024-09-010
PRE
Fibroblast Activation Protein α-Directed Imaging and Therapy of Solitary Fibrous Tumor

成纤维细胞活化蛋白 α 定向显像与孤立性纤维瘤的治疗

2024-01-043
OA
Multi-omic and functional analysis for classification and treatment of sarcomas with FUS-TFCP2 or EWSR1-TFCP2 fusions

基于FUS-TFCP2或EWSR1-TFCP2融合基因的肉瘤分类与治疗的多组学及功能分析

2024-01-023
OAAI
Etiology-independent activation of the LTβ-LTβR-RELB axis drives aggressiveness and predicts poor prognosis in Hepatocellular carcinoma
2023-11-023
PRE
NCT/DKFZ MASTER handbook of interpreting whole-genome, transcriptome, and methylome data for precision oncology
2023-10-267
OAAI